Lanean...

Surfactants in the Management of Respiratory Distress Syndrome in Extremely Premature Infants

Respiratory distress syndrome (RDS) is primarily due to decreased production of pulmonary surfactant, and it is associated with significant neonatal morbidity and mortality. Exogenous pulmonary surfactant therapy is currently the treatment of choice for RDS, as it demonstrates the best clinical and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Ramanathan, Rangasamy
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Pediatric Pharmacy Advocacy Group 2006
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468090/
https://ncbi.nlm.nih.gov/pubmed/23118650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-11.3.132
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!